Willner & Heller, LLC Moderna, Inc. Transaction History

Willner & Heller, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$28.35 - $47.53 $62,795 - $105,278	2,215 Added 31.55%	9,235 $261,000
Q4 2024 Jan 16, 2025	SELL	$36.85 - $63.93 $10,133 - $17,580	-275 Reduced 3.77%	7,020 $291,000
Q3 2024 Oct 10, 2024	BUY	$63.64 - $125.14 $464,253 - $912,896	7,295 New	7,295 $487,000

845

257M

39.6M

43.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $9.69B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Willner & Heller, LLC, based on Form 13F filings with the SEC.

Stay updated on Willner & Heller, LLC with notifications on news.